Loading clinical trials...
Loading clinical trials...
In Mexico, upper lacrimal duct obstruction (ULDO) is a common pathology, and the standard surgical treatment is closed dracryointubation. Based on statistics from our headquarters, in 30% of cases the...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
NCT07225244 · Primary Acquired Nasolacrimal Duct Obstruction
NCT05999630 · Nasolacrimal Duct Obstruction, Thyroid Cancer
NCT07154121 · Primary Acquired Nasolacrimal Duct Obstruction
NCT06530264 · Acquired Nasolacrimal Duct Obstruction
NCT06983717 · Lacrimal Stenosis of Both Eyes
Institiuto de Oftalmología Fundación Conde de Valenciana
Mexico City
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions